Actualités Hydromer Inc (CE) - HYDI | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for the Year Ended December 31, 2024

CONCORD, NC -- April 8, 2025 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the "Company"), a leader in hydrophilic...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024

CONCORD, N.C. -- October 24, 2024 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic...

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development

· Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings...

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update

CONCORD, NC -- August 7, 2024 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic...

Hydromer Announces Attainment of ISO 13485 Certification

CONCORD, NC -- June 17, 2024 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the "Company"), a leader in hydrophilic...

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology

CONCORD, NC -- June 5, 2024 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the "Company"), a leader in hydrophilic, thromboresistant, and...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024

CONCORD, NC -- April 29, 2024 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic...

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations CONCORD...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hydromer Inc (CE) (HYDI)

Outils de qualité professionnelle, pour des investisseurs individuels.

HYDI Actualités

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for the Year Ended December 31, 2024

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update

Hydromer Announces Attainment of ISO 13485 Certification

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations

Hydromer, Inc. Unveils Rebranding Initiatives Reflecting Its Transformation and Focus on Growth and Innovation

Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel

Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti

Hydromer Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara

Hydromer Inc. Shares Message from CEO Michael E. Torti

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hydromer Inc (CE) (HYDI) Actualités

Hydromer Inc (CE) (HYDI)

Outils de qualité professionnelle, pour des investisseurs individuels.

HYDI Actualités

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for the Year Ended December 31, 2024

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update

Hydromer Announces Attainment of ISO 13485 Certification

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations

Hydromer, Inc. Unveils Rebranding Initiatives Reflecting Its Transformation and Focus on Growth and Innovation

Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel

Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti

Hydromer Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara

Hydromer Inc. Shares Message from CEO Michael E. Torti

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités